Yes Leslie has stated that IMU will not progress to a phase 3 study instead choosing to do another phase two trial, looking at the effectiveness of HER-Vaxx at a higher dosage rate. It will also assess other treatment combinations that it can trial its on Olympic virus with.
interestingly, IMU states that if it was to progress to a phase three study, this would require thousands of patients and tens of millions of dollars and take more than a decade.
Leslie then goes on to state that that IMU would pursue licensing agreements, or consider acquisition offers for its therapy candidates.
Yes Leslie has stated that IMU will not progress to a phase 3...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
-0.002(3.51%) |
Mkt cap ! $402.5M | |||
| Open | High | Low | Value | Volume |
| 5.7¢ | 5.7¢ | 5.4¢ | $1.042M | 18.87M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 628179 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 897037 | 6 |
View Market Depth
| Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |